|
⚲
|
| Keyboard |
| HealthCap VII GP Sa | |
|---|---|
| Firm | HealthCap VII Advisor AB |
| Address | 18 Avenue Douchy Lausanne, V8 1006 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| HealthCap VII Advisor AB | |||||
| HealthCap VII LP | 021-242994 | Director | 160.4 M of 220.0 M |
131.6 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Fusion Pharmaceuticals Inc FUSN
Class A Preferred Exchangeable Shares · derivative
|
2020-06-30 | Conversion | 13,333,333 | ||
|
Fusion Pharmaceuticals Inc FUSN
Common Shares
|
2020-06-30 | Conversion | 2,497,345 | ||
|
Fusion Pharmaceuticals Inc FUSN
Common Shares
|
2020-06-30 | Conversion | 1,069,902 | ||
|
Fusion Pharmaceuticals Inc FUSN
Common Shares
|
2020-06-30 | Buy | 240,000 | $17.00 | 4,080,000 |
|
Fusion Pharmaceuticals Inc FUSN
Class B Preferred Exchangeable Shares · derivative
|
2020-06-30 | Conversion | 5,712,216 | ||
|
Aprea Therapeutics Inc APRE
Common Stock
|
2019-10-07 | Buy | 266,667 | $15.00 | 4,000,005 |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2019-10-07 | Conversion | 427,496 | ||
|
Aprea Therapeutics Inc APRE
Common Stock
|
2019-10-07 | Conversion | 1,661,382 | ||
|
Aprea Therapeutics Inc APRE
Series C Convertible Preferred Stock · derivative
|
2019-10-07 | Conversion | 427,496 | ||
|
Aprea Therapeutics Inc APRE
Series B Convertible Preferred Stock · derivative
|
2019-10-07 | Conversion | 1,661,382 |